Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.


In the US, Solu-Medrol (methylprednisolone systemic) is a member of the drug class glucocorticoids and is used to treat Adrenogenital Syndrome, Allergic Rhinitis, Asthma, Asthma - acute, Asthma - Maintenance, Dermatologic Lesion, Gout - Acute, Immunosuppression, Inflammatory Conditions, Multiple Sclerosis, Neuralgia, Osteoarthritis, Rheumatoid Arthritis, Shock and Ulcerative Colitis - Active.

US matches:

Ingredient matches for Solu-Medrol


Methylprednisolone is reported as an ingredient of Solu-Medrol in the following countries:

  • Cyprus
  • Ecuador
  • Egypt
  • Latvia
  • Lithuania
  • Peru
  • Taiwan
  • Tunisia

Methylprednisolone 21-(sodium succinate) (a derivative of Methylprednisolone) is reported as an ingredient of Solu-Medrol in the following countries:

  • Argentina
  • Australia
  • Belgium
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • Greece
  • Hong Kong
  • Iceland
  • Indonesia
  • Italy
  • Japan
  • Kuwait
  • Lithuania
  • Malaysia
  • Mexico
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Singapore
  • Slovakia
  • South Africa
  • Sweden
  • Thailand
  • United States
  • Vietnam

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.